Connect with us

Hi, what are you looking for?

Stock

European stocks slip slightly; UK economy contracted in September

Investing.com – European stock markets slipped slightly Friday, as investors digested disappointing UK growth data, French inflation numbers as well as hawkish comments from Fed chair Jerome Powell. 

At 10:35 ET (15:35 GMT), the DAX index in Germany traded 0.1% lower, the CAC 40 in France fell 0.3%, and the FTSE 100 in the U.K. dropped 0.1%.

UK economy contracted in September 

Britain’s economy contracted unexpectedly in September, data showed on Friday, as gross domestic product slipped by 0.1% in monthly terms during September.

For the third quarter as a whole, the economy grew by 0.1%, slowing from 0.5% growth during the second quarter, and below the 0.2% expansion the Bank of England had forecast.

This followed data released on Thursday showing the eurozone grew only 0.4% in the third quarter, with the bloc’s largest component – the German economy – particularly weak.

Additionally, consumer prices in France, the eurozone’s second-biggest economy, rose 1.6% year-on-year in October, revising slightly up its preliminary reading of 1.5% published late last month.

Also weighing were relatively hawkish comments by Jerome Powell, with the Fed chairman signaling on Thursday that the US central bank doesn’t need to rush to cut interest rates further, especially given the uncertainty surrounding the return of President-elect Donald Trump to the White House.

Evotec soars on potential purchase

In the European corporate sector, Evotec (ETR:EVTG) jumped over 20% after Halozyme Therapeutics (NASDAQ:HALO) said it has proposed buying the German drug developer.

European vaccine makers also came under pressure, with both Sanofi (NASDAQ:SNY) and GSK (LON:GSK) over 3% lower after Trump selected Robert F. Kennedy Jr., a vaccine skeptic, to lead the Department of Health and Human Services.

Land Securities (LON:LAND) stock rose over 3% after the UK commercial property firm forecast annual earnings above market expectations.

Crude prices hit by demand concerns 

Crude prices fell Friday, and were on track for hefty weekly losses on concerns that China, the world’s biggest crude importer, is continuing to struggle with an uneven economic recovery.

By 10:35 ET, the U.S. crude futures (WTI) dropped 1.1% to $67.92 a barrel, while the Brent contract fell 1% to $71.81 a barrel.

For the week, both contracts are set to drop around 3%.

Economic data released earlier in the session had painted an uncertain picture of the Chinese economy, while the numbers also indicated that China’s oil refiners in October processed 4.6% less crude than a year earlier, falling year-on-year for a seventh month.

Prices were rattled by a cut in OPEC’s demand outlook this week, while US oil inventories grew nearly 2.1 million barrels in the week to November 8, pushing up concerns over a supply glut, especially as US production remained close to record highs of over 13 million barrels per day. 

The International Energy Agency, in its monthly report on Thursday, had warned that robust production will see oil supplies exceed demand in 2025, even if the Organization of Petroleum Exporting Countries, and allies, left ongoing supply cuts in place. 

 

 

This post appeared first on investing.com






    You May Also Like

    Editor's Pick

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    Latest News

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com